期刊文献+

蔗糖铁注射液治疗老年缺铁性贫血疗效观察 被引量:3

Clinical observation of iron sucrose injection in treating old patients with iron deficiency anemia
原文传递
导出
摘要 目的观察蔗糖铁注射液治疗老年缺铁性贫血(IDA)的疗效和不良反应。方法选择32例老年IDA患者,按随机数字表法分为静脉组(17例)和口服组(15例),观察两种方法对改善贫血的疗效和不良反应。结果治疗后静脉组及口服组血红蛋白(1ib)均较治疗前升高,分别为(100.18±8.71)g,L和(85.80±6.92)g/L,两组比较差异有统计学意义(P〈0.01);治疗后血清铁亦有上升,两组分别为(23.84±5.34)μmol/L和(14.63±3.29)μmol/L,与治疗前比较差异有统计学意义(P〈0.01)。静脉组无明显不良反应发生,口服组有6例(40%)发生胃肠道反应。结论静脉用蔗糖铁可作为老年IDA患者补铁方式,疗效优于口服铁剂,且不良反应发生率低。 Objective To observe the effect and adverse reactions of iron sucrose injection in treating old patients with iron deficiency anemia (IDA). Methods Thirty-two old patients with IDA were divided into injection group (17 patients) and oral group( 15 patients) by random digits table. The effects of improvemeht on IDA and their adverse reactions were observed. Results After treatment, hemoglobin (Hb) in the injection group and oral group was ( 100.18 ± 8.71 ) g/L and (85.80 ± 6.92)g/L(P 〈 0.01 ), and serum iron was (23.84 ±5.34) μmol/L and ( 14.63 ± 3.29) μmol/L (P 〈 0.01 ). There were no obvious adverse reactions in injection group, whereas there were 6 cases(40% ) with gastric and colon adverse reaction in oral group. Conclusions The treatment of intravenous injection of iron sucrose can be effectively used to cure old patients with IDA. It has better effect and has lower rate of adverse reaction.
出处 《中国医师进修杂志》 2011年第7期26-27,共2页 Chinese Journal of Postgraduates of Medicine
关键词 贫血 缺铁性 老年人 蔗糖铁注射液 Anemia,iron-deficiency Aged Iron sucrose injection
  • 相关文献

参考文献7

二级参考文献9

  • 1Nissenson AR, strobes J. Iron deficiency in patients with renal failure. Kidney Int, 1999,69 (suppl) : S28-S21.
  • 2Collins AJ, Influence of target hemoglobin in dialysis patients on morbidity and mortality. Kidney Int,2002,80(suppl) :44-48.
  • 3Fudin R, J, Shostak A et al. Correction of uremic iron deficiency anemia in hemodialyzed patients: A prospective study Ncphron, 1998,79(2) :299-305.
  • 4Macdougall C. Optimizing therapy. Cruu Opin Hematol, 1999,6: 121-126.
  • 5Besarab A ,Amin N ,Ahsan M ,et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis vpatients. Jam Soc Nephro1,2000 ,11:530-538.
  • 6De Vite MV,Frumkin D,Mittat S,Kamran A,Fishbane S,Michelis MF. Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropotein requirement in hemodialysis patients. Clin Nephrol,2003 ,60 :335-340.
  • 7NKF-K/DOQI慢性肾脏病贫血治疗的临床实践指南[J].中国血液净化,2007,6(9):507-516. 被引量:17
  • 8季大玺.重视肾性贫血患者静脉铁剂的合理应用[J].肾脏病与透析肾移植杂志,2008,17(4):349-350. 被引量:18
  • 9汪关煜,林善锬,叶朝阳,吴兆龙,徐培桢,林爱武,朱汉威.多糖铁复合物对肾性贫血肾功能衰竭血液透析患者的补铁疗效与安全性观察[J].中华内科杂志,2000,39(6):380-383. 被引量:44

共引文献45

同被引文献12

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部